Nugraha Ryan Rachmad, Miranda Adriana Viola, Ahmadi Attaullah, Lucero-Prisno Don Eliseo
USAID Health Financing Activity/ThinkWell, Jakarta, Indonesia.
Faculty of Medicine, University of Indonesia, Depok, West Java, Indonesia.
Trop Med Health. 2021 Sep 22;49(1):76. doi: 10.1186/s41182-021-00367-3.
Coronavirus disease-19 (COVID-19) has been spreading in every part of the world, putting nations at risk with its pandemic status, including Indonesia. COVID-19 vaccine has been deemed as one of the most effective interventions to date for mitigating the spread and mortality from COVID-19. Responding to the situation, the Government of Indonesia (GOI) has allocated the means necessary to procure and distribute COVID-19 vaccines; placing into consideration the unique context of the country, recently categorized as a middle-income country and archipelagic with a population over 270 million. This article aims to present the challenges associated with the distribution of COVID-19 vaccination as well as recommendations to mitigate them, to ensure a timely and effective COVID-19 vaccination program in Indonesia.
新型冠状病毒肺炎(COVID-19)已在世界各国蔓延,因其大流行状态使各国面临风险,印度尼西亚也不例外。COVID-19疫苗被认为是迄今为止减轻COVID-19传播和死亡率的最有效干预措施之一。针对这一情况,印度尼西亚政府已拨出采购和分发COVID-19疫苗所需的资源;考虑到该国的独特背景,该国最近被归类为中等收入国家,是一个群岛国家,人口超过2.7亿。本文旨在介绍与COVID-19疫苗接种分配相关的挑战以及减轻这些挑战的建议,以确保印度尼西亚的COVID-19疫苗接种计划及时、有效。